{"disease":{"id":"primary-sclerosing-cholangitis-psc","name":"primary sclerosing cholangitis psc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04753996","title":"Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT01672853","title":"Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":235,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03146936","title":"Swiss Primary Sclerosing Cholangitis Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Fondazione Epatocentro Ticino","has_results":false},{"nct_id":"NCT06686810","title":"Endoscopy and Primary Sclerosing Cholangitis","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06975150","title":"Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"CuromeBiosciences","has_results":false},{"nct_id":"NCT06905054","title":"Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05082779","title":"Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Cascade Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT02177136","title":"Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Intercept Pharmaceuticals","has_results":true},{"nct_id":"NCT06026865","title":"S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT03333928","title":"A POC and Dose-Ranging Study of HTD1801 in PSC Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":true},{"nct_id":"NCT02808312","title":"Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03766035","title":"Cholangioscopy in Primary Sclerosing Cholangitis (PSC)","phase":"","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Boston Scientific Corporation","has_results":false},{"nct_id":"NCT06037577","title":"Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"ChemomAb Ltd.","has_results":false},{"nct_id":"NCT04015310","title":"Quantitative Magnetic Resonance Imaging in Biliary Disease: Health Economics Study","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Perspectum","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}